BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 32178718)

  • 61. The methyl-CpG-binding protein MeCP2 and neurological disease.
    Bird A
    Biochem Soc Trans; 2008 Aug; 36(Pt 4):575-83. PubMed ID: 18631120
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Design and Application of DNA Modification-Specific Transcription-Activator-Like Effectors.
    Buchmuller B; Muñoz-López Á; Gieß M; Summerer D
    Methods Mol Biol; 2021; 2198():381-399. PubMed ID: 32822046
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The methyl-CpG binding transcriptional repressor MeCP2 stably associates with nucleosomal DNA.
    Chandler SP; Guschin D; Landsberger N; Wolffe AP
    Biochemistry; 1999 Jun; 38(22):7008-18. PubMed ID: 10353812
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Towards an understanding of DNA recognition by the methyl-CpG binding domain 1.
    Rauch C; Trieb M; Wibowo FR; Wellenzohn B; Mayer E; Liedl KR
    J Biomol Struct Dyn; 2005 Jun; 22(6):695-706. PubMed ID: 15842174
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The minimal repression domain of MBD2b overlaps with the methyl-CpG-binding domain and binds directly to Sin3A.
    Boeke J; Ammerpohl O; Kegel S; Moehren U; Renkawitz R
    J Biol Chem; 2000 Nov; 275(45):34963-7. PubMed ID: 10950960
    [TBL] [Abstract][Full Text] [Related]  

  • 66. MeCP2 binds to non-CG methylated DNA as neurons mature, influencing transcription and the timing of onset for Rett syndrome.
    Chen L; Chen K; Lavery LA; Baker SA; Shaw CA; Li W; Zoghbi HY
    Proc Natl Acad Sci U S A; 2015 Apr; 112(17):5509-14. PubMed ID: 25870282
    [TBL] [Abstract][Full Text] [Related]  

  • 67. MBD2 and MeCP2 regulate distinct transitions in the stage-specific differentiation of olfactory receptor neurons.
    Macdonald JL; Verster A; Berndt A; Roskams AJ
    Mol Cell Neurosci; 2010 May; 44(1):55-67. PubMed ID: 20188178
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Expression of Dnmt1, demethylase, MeCP2 and methylation of tumor-related genes in human gastric cancer.
    Fang JY; Cheng ZH; Chen YX; Lu R; Yang L; Zhu HY; Lu LG
    World J Gastroenterol; 2004 Dec; 10(23):3394-8. PubMed ID: 15526354
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Role of DNA methylation and methyl-DNA binding proteins in the repression of 5-lipoxygenase promoter activity.
    Katryniok C; Schnur N; Gillis A; von Knethen A; Sorg BL; Looijenga L; Rådmark O; Steinhilber D
    Biochim Biophys Acta; 2010 Jan; 1801(1):49-57. PubMed ID: 19781662
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Systematic prediction of DNA shape changes due to CpG methylation explains epigenetic effects on protein-DNA binding.
    Rao S; Chiu TP; Kribelbauer JF; Mann RS; Bussemaker HJ; Rohs R
    Epigenetics Chromatin; 2018 Feb; 11(1):6. PubMed ID: 29409522
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Methylation-mediated proviral silencing is associated with MeCP2 recruitment and localized histone H3 deacetylation.
    Lorincz MC; Schübeler D; Groudine M
    Mol Cell Biol; 2001 Dec; 21(23):7913-22. PubMed ID: 11689684
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Epigenetic regulation of RELN and GAD1 in the frontal cortex (FC) of autism spectrum disorder (ASD) subjects.
    Zhubi A; Chen Y; Guidotti A; Grayson DR
    Int J Dev Neurosci; 2017 Nov; 62():63-72. PubMed ID: 28229923
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Methyl-CpG-binding domain proteins: readers of the epigenome.
    Du Q; Luu PL; Stirzaker C; Clark SJ
    Epigenomics; 2015; 7(6):1051-73. PubMed ID: 25927341
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Characterization and directed evolution of a methyl-binding domain protein for high-sensitivity DNA methylation analysis.
    Heimer BW; Tam BE; Sikes HD
    Protein Eng Des Sel; 2015 Dec; 28(12):543-51. PubMed ID: 26384511
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Understanding the structural and dynamic consequences of DNA epigenetic modifications: computational insights into cytosine methylation and hydroxymethylation.
    Carvalho AT; Gouveia L; Kanna CR; Wärmländer SK; Platts JA; Kamerlin SC
    Epigenetics; 2014 Dec; 9(12):1604-12. PubMed ID: 25625845
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Emerging physiological and pathological roles of MeCP2 in non-neurological systems.
    Wang J; Xiao Y; Liu C; Huang Y; Petersen RB; Zheng L; Huang K
    Arch Biochem Biophys; 2021 Mar; 700():108768. PubMed ID: 33485848
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Proteins That Read DNA Methylation.
    Shimbo T; Wade PA
    Adv Exp Med Biol; 2016; 945():303-320. PubMed ID: 27826844
    [TBL] [Abstract][Full Text] [Related]  

  • 78. MeCP2 AT-Hook1 mutations in patients with intellectual disability and/or schizophrenia disrupt DNA binding and chromatin compaction in vitro.
    Sheikh TI; Harripaul R; Ayub M; Vincent JB
    Hum Mutat; 2018 May; 39(5):717-728. PubMed ID: 29431277
    [TBL] [Abstract][Full Text] [Related]  

  • 79. DNA sequencing: detecting methylation with force.
    Marszalek PE
    Nat Nanotechnol; 2010 Nov; 5(11):765-6. PubMed ID: 21048791
    [No Abstract]   [Full Text] [Related]  

  • 80. Density Control over MBD2 Receptor-Coated Surfaces Provides Superselective Binding of Hypermethylated DNA.
    Kolkman RW; Michel-Souzy S; Wasserberg D; Segerink LI; Huskens J
    ACS Appl Mater Interfaces; 2022 Sep; 14(36):40579-40589. PubMed ID: 36052432
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.